Form 8-K - Current report:
SEC Accession No. 0001144204-15-067493
Filing Date
2015-11-23
Accepted
2015-11-23 16:05:21
Documents
22
Period of Report
2015-11-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v425463_8k.htm 8-K 15768
2 EXHIBIT 99.1 v425463_ex99-1.htm EX-99.1 23991
3 GRAPHIC image_001.jpg GRAPHIC 58380
4 GRAPHIC image_002.jpg GRAPHIC 154772
5 GRAPHIC image_003.jpg GRAPHIC 121521
6 GRAPHIC image_004.jpg GRAPHIC 105931
7 GRAPHIC image_005.jpg GRAPHIC 85099
8 GRAPHIC image_006.jpg GRAPHIC 57042
9 GRAPHIC image_007.jpg GRAPHIC 95649
10 GRAPHIC image_008.jpg GRAPHIC 77175
11 GRAPHIC image_009.jpg GRAPHIC 60477
12 GRAPHIC image_010.jpg GRAPHIC 102299
13 GRAPHIC image_011.jpg GRAPHIC 98177
14 GRAPHIC image_012.jpg GRAPHIC 60384
15 GRAPHIC image_013.jpg GRAPHIC 72579
16 GRAPHIC image_014.jpg GRAPHIC 91201
17 GRAPHIC image_015.jpg GRAPHIC 68048
18 GRAPHIC image_016.jpg GRAPHIC 99456
19 GRAPHIC image_017.jpg GRAPHIC 88034
20 GRAPHIC image_018.jpg GRAPHIC 106672
21 GRAPHIC image_019.jpg GRAPHIC 80626
22 GRAPHIC image_020.jpg GRAPHIC 84726
  Complete submission text file 0001144204-15-067493.txt   2478534
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 151249748
SIC: 2836 Biological Products, (No Diagnostic Substances)